Health

EssilorLuxottica acquires the Canadian med-tech start-up CellviewEssilorLuxottica acquires the Canadian med-tech start-up Cellview

EssilorLuxottica acquires the Canadian med-tech start-up Cellview

EssilorLuxottica acquires the Canadian med-tech start-up Cellview The company’s ultra-widefield proprietary technology allows for fast and easy high-quality images, providing…

2 days ago
Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfrontNovartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is…

2 days ago
Novonesis to acquire dsm-firmenichs share of the Feed Enzyme AllianceNovonesis to acquire dsm-firmenichs share of the Feed Enzyme Alliance

Novonesis to acquire dsm-firmenichs share of the Feed Enzyme Alliance

Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution…

2 days ago
Tevogen Bio’s Business Model Addresses Biopharma Industry Challenges with Cost-Efficient InnovationTevogen Bio’s Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation

Tevogen Bio’s Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation

WARREN, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), is a…

2 days ago
HNL Lab Medicine Employees Select Local Charities for Annual DonationHNL Lab Medicine Employees Select Local Charities for Annual Donation

HNL Lab Medicine Employees Select Local Charities for Annual Donation

ALLENTOWN, Pa., Feb. 10, 2025 (GLOBE NEWSWIRE) -- HNL Lab Medicine believes in the importance of communities coming together to…

2 days ago
Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01

Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01

STAFFORD, Texas, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused…

3 days ago
Philips, World Bank, and Ukraine Ministry of Health announce successful deployment of nationwide acute stroke care upgrade, helping thousands of patientsPhilips, World Bank, and Ukraine Ministry of Health announce successful deployment of nationwide acute stroke care upgrade, helping thousands of patients

Philips, World Bank, and Ukraine Ministry of Health announce successful deployment of nationwide acute stroke care upgrade, helping thousands of patients

February 10, 2025 Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading…

3 days ago
ENA Respiratory Receives US$5m Investment from Flu Lab to Support Clinical Development of Novel Intranasal Antiviral Host Defence Immune Enhancer, INNA-051ENA Respiratory Receives US$5m Investment from Flu Lab to Support Clinical Development of Novel Intranasal Antiviral Host Defence Immune Enhancer, INNA-051

ENA Respiratory Receives US$5m Investment from Flu Lab to Support Clinical Development of Novel Intranasal Antiviral Host Defence Immune Enhancer, INNA-051

MELBOURNE, Australia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence immune enhancers…

3 days ago
Pharming Group to participate in February investor conferencePharming Group to participate in February investor conference

Pharming Group to participate in February investor conference

Leiden, the Netherlands, February 10, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in…

3 days ago
GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs HoldersGENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs Holders

GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs Holders

In conjunction with the royalty financing deal with HealthCare Royalty (HCRx) announced on January 30, 2025, GENFIT will request the…

3 days ago